1
|
Bose A, Valdivia-Berroeta GA, Gonnella NC. Predicting Autoxidation of Sulfides in Drug-like Molecules Using Quantum Mechanical/Density Functional Theory Methods. J Chem Inf Model 2024; 64:128-137. [PMID: 38127785 DOI: 10.1021/acs.jcim.3c01158] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2023]
Abstract
Autoxidation of drugs and drug-like molecules is a major concern in the development of safe and effective therapeutics. Because active pharmaceutical ingredients (APIs) that contain sulfur atoms can form sulfoxides under oxidative stress, predicting oxidative susceptibilities within an organic molecule can have a major impact in accelerating the compound's stability assessment. For investigation of a sulfur atom's oxidative stability, density functional theory (DFT) methods were applied to accurately predict S-O estimated bond dissociation enthalpies (BDEs) of sulfoxides. Our process employed B3LYP/6-31+G(d) for geometry optimization and frequency calculation, and we employed B3P86/6-311++G(2df,2p) to obtain electronic energies from single-point energy calculations. A total of 84 drug-like molecules containing 50 different sulfide scaffolds were used to develop a risk scale. Our results showed that when S-O BDE is less than 69 kcal/mol, the sulfur atom has low oxidative susceptibility. High oxidation risk occurs when the S-O BDE is greater than 75 kcal/mol. The risk scale was successful in predicting the relative propensities of sulfide oxidation among the small organic molecules and commercial drugs examined.
Collapse
Affiliation(s)
- Arnab Bose
- Material and Analytical Sciences, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Gabriel A Valdivia-Berroeta
- Material and Analytical Sciences, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| | - Nina C Gonnella
- Material and Analytical Sciences, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877, United States
| |
Collapse
|
2
|
Annereau M, Vignes M, Denis L, Rieutord A, Legrand FX, Rioblanc F, Paul M, Grill J, Secretan PH, Do B. Molecular Mechanisms Involved in the Chemical Instability of ONC201 and Methods to Counter Its Degradation in Solution. Pharmaceutics 2023; 15:2371. [PMID: 37896134 PMCID: PMC10609984 DOI: 10.3390/pharmaceutics15102371] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2023] [Revised: 09/19/2023] [Accepted: 09/20/2023] [Indexed: 10/29/2023] Open
Abstract
Glioblastoma is one of the most common and aggressive forms of brain tumor, a rare disease for which there is a great need for innovative therapies. ONC201, a new drug substance, has been used in a compassionate treatment program where the choice of dosage form and regimen have yet to be justified. The prior knowledge needed to anticipate ONC201 stability problems has recently been partially addressed, by (i) showing that ONC201 is sensitive to light and oxidation and (ii) identifying the molecular structures of the main degradation products formed. The aim of the work presented here was to improve our understanding of the degradation pathways of ONC201 using data from ab initio calculations and experimental work to supplement the structural information we already published. The C-H bonds located αto the amine of the tetrahydropyridine group and those located alpha to the imine function of the dihydroimidazole group exhibit the lowest bond dissociation energies (BDEs) within the ONC201 molecule. Moreover, these values drop well below 90 kcal.mol-1 when ONC201 is in an excited state (S1; T1). The structures of the photoproducts we had previously identified are consistent with these data, showing that they would have resulted from radical processes following the abstraction of alpha hydrogens. Concerning ONC201's sensitivity to oxidation, the structures of the oxidation products matched the critical points revealed through mapped electrostatic potential (MEP) and average local ionization energy (ALIE). The data obtained from ab initio calculations and experimental work showed that the reactivity of ONC201 to light and oxidation conditions is highly dependent on pH. While an acidic environment (pH < 6) contributes to making ONC201 quantitatively more stable in solution in the face of oxidation and photo-oxidation, it nevertheless seems that certain chemical groups in the molecule are more exposed to nucleophilic attacks, which explains the variation observed in the profile of degradation products formed in the presence of certain antioxidants tested. This information is crucial to better understand the stability results in the presence of antioxidant agents and to determine the right conditions for them to act.
Collapse
Affiliation(s)
- Maxime Annereau
- Université Paris-Saclay, 91400 Orsay, France; (M.A.); (M.V.); (B.D.)
- Clinical Pharmacy Department, Gustave Roussy Cancer Campus, 94800 Villejuif, France; (L.D.); (A.R.); (F.R.)
| | - Marina Vignes
- Université Paris-Saclay, 91400 Orsay, France; (M.A.); (M.V.); (B.D.)
- Clinical Pharmacy Department, Gustave Roussy Cancer Campus, 94800 Villejuif, France; (L.D.); (A.R.); (F.R.)
| | - Lucas Denis
- Clinical Pharmacy Department, Gustave Roussy Cancer Campus, 94800 Villejuif, France; (L.D.); (A.R.); (F.R.)
| | - André Rieutord
- Clinical Pharmacy Department, Gustave Roussy Cancer Campus, 94800 Villejuif, France; (L.D.); (A.R.); (F.R.)
| | | | - François Rioblanc
- Clinical Pharmacy Department, Gustave Roussy Cancer Campus, 94800 Villejuif, France; (L.D.); (A.R.); (F.R.)
| | - Muriel Paul
- Department of Pharmacy, Henri Mondor Hospital, AP-HP, 94000 Creteil, France;
- EpidermE, Université Paris Est Creteil, 94000 Creteil, France
| | - Jacques Grill
- Molecular Predictors and New Targets in Oncology, INSERM, Gustave Roussy, Université Paris-Saclay, 94800 Villejuif, France;
- Département de Cancérologie de l’Enfant et de l’Adolescent, Gustave Roussy, Université Paris-Saclay, 94800 Villejuif, France
| | | | - Bernard Do
- Université Paris-Saclay, 91400 Orsay, France; (M.A.); (M.V.); (B.D.)
- Department of Pharmacy, Henri Mondor Hospital, AP-HP, 94000 Creteil, France;
| |
Collapse
|